http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20000068070-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
| filingDate | 1997-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2000-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20000068070-A |
| titleOfInvention | Orally applicable formulation of quinolone or naphthyridonecarboxylic acids |
| abstract | The present invention, when the dry mixture is used in the presence of water, itself in the form of an excipient, optionally in the presence of an adjuvant, itself in the form of its own or water-soluble salts or derivatives, preferably in the form of an aqueous salt solution Or orally administering quinolone- or naphthyridonecarboxylic acid, characterized in that it is mixed with embonic acid in the form of a water-soluble salt or derivative, preferably in the form of an aqueous salt solution, and optionally converts the resulting mixture into a further ready-to-use form. It relates to a method of preparing a possible formulation. |
| priorityDate | 1996-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 133.